been submitted based on separate financial statements only.) Summary overview From the end of 1st quarter of 2020, the epidemic situation of the coronavirus disease 2019 (COVID-19) has negatively

approximately 1.28 million baht and interest income from the disposal of investment in subsidiaries in amount of 2.01 million baht, although this year there is corona 2019 epidemic situation, which affects all

, mainly come from 1)Customers delay some of the project construction plan, thus it is not possible for making construction and revenue recognition 2)The economics slowdown due to the COVID-19 epidemic, thus

steadily increased in recent years which result to the strict in granting a loan to the borrower from many financial institutions. As well as, the epidemic of Covid 19 have severe negative impacts on the

to the COVID-19 epidemic, thus major company’s customer espeacially in real estate sector delay in launching new projects. The recognition of construction and services for the first nine months of 2020

of 53 .75 million baht or 76 .68 percent due to the company’s announcement of the cessation of operations from the impact of the coronavirus disease (COVID-19 ) epidemic, and tourists decreased

DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 1 of 3 No. DOD026/2563 February 26, 2020 Subject Management Discussion and Analysis of for

DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 1 (Translate) NO. DOD 030/2019 August 13, 2019 Subject: Clarification of the operating

DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 1 (Translate) NO. DOD 035/2019 November 11, 2019 Subject: Clarification of the operating

Microsoft Word - MD&A.EN (Revised 3) (1) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon